- Report
- October 2026
- 174 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 380 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 565 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 470 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 484 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- October 2026
- 487 Pages
Global
From €5434EUR$5,850USD£4,546GBP
- Report
- July 2026
- 130 Pages
Global
From €4412EUR$4,750USD£3,691GBP
- Report
- July 2026
- 120 Pages
Global
From €4412EUR$4,750USD£3,691GBP
- Report
- August 2026
- 171 Pages
Global
From €3669EUR$3,950USD£3,069GBP
- Report
- May 2026
- 147 Pages
Global
From €3669EUR$3,950USD£3,069GBP
- Report
- January 2026
- 150 Pages
Global
From €3669EUR$3,950USD£3,069GBP
- Report
- February 2026
- 200 Pages
Global
From €4640EUR$4,995USD£3,881GBP
- Report
- January 2026
- 200 Pages
Global
From €4640EUR$4,995USD£3,881GBP
- Report
- August 2026
- 160 Pages
Global
From €3084EUR$3,320USD£2,580GBP
€3855EUR$4,150USD£3,225GBP
- Report
- January 2026
- 160 Pages
Global
From €2935EUR$3,160USD£2,456GBP
€3669EUR$3,950USD£3,069GBP
- Report
- April 2026
- 924 Pages
Global
From €4133EUR$4,450USD£3,458GBP
- Report
- February 2026
Middle East, Africa, Global Middle East, Africa, Global
From €3205EUR$3,450USD£2,681GBP
- Report
- July 2026
- 125 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- February 2026
- 98 Pages
Global
From €3500EUR$4,036USD£3,031GBP
- Report
- December 2025
- 150 Pages
Global
From €4505EUR$4,850USD£3,769GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more